Construction and Characterization of a High-Capacity Replication-Competent Murine Cytomegalovirus Vector for Gene Delivery
Author:
Riedl André12, Bojková Denisa123, Tan Jiang12, Jeney Ábris2, Larsen Pia-Katharina4, Jeney Csaba5, Full Florian12, Kalinke Ulrich4ORCID, Ruzsics Zsolt12
Affiliation:
1. Medical Center, Institute of Virology, University of Freiburg, 79104 Freiburg, Germany 2. Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany 3. Institute of Medical Virology, Goethe University Frankfurt, University Hospital, 60596 Frankfurt am Main, Germany 4. TWINCORE, Centre for Experimental and Clinical Infection Research, a Joint Venture between the Hanover Medical School and the Helmholtz Centre for Infection Research, Institute for Experimental Infection Research, 30625 Hanover, Germany 5. Department of Microsystems Engineering—IMTEK, University of Freiburg, 79110 Freiburg, Germany
Abstract
We investigated the basic characteristics of a new murine cytomegalovirus (MCMV) vector platform. Using BAC technology, we engineered replication-competent recombinant MCMVs with deletions of up to 26% of the wild-type genome. To this end, we targeted five gene blocks (m01-m17, m106-m109, m129-m141, m144-m158, and m159-m170). BACs featuring deletions from 18% to 26% of the wild-type genome exhibited delayed virus reconstitution, while smaller deletions (up to 16%) demonstrated reconstitution kinetics similar to those of the wild type. Utilizing an innovative methodology, we introduced large genomic DNA segments, up to 35 kbp, along with reporter genes into a newly designed vector with a potential cloning capacity of 46 kbp (Q4). Surprisingly, the insertion of diverse foreign DNAs alleviated the delayed plaque formation phenotype of Q4, and these large inserts remained stable through serial in vitro passages. With reporter-gene-expressing recombinant MCMVs, we successfully transduced not only mouse cell lines but also non-rodent mammalian cells, including those of human, monkey, bovine, and bat origin. Remarkably, even non-mammalian cell lines derived from chickens exhibited successful transduction.
Funder
Deutsche Forschungsgemeinschaft Joint French–German Project cGAS-VAC
Reference87 articles.
1. Immunologic considerations for generating memory CD8 T cells through vaccination;Butler;Cell Microbiol.,2011 2. On natural and artificial vaccinations;Zinkernagel;Annu. Rev. Immunol.,2003 3. Hansen, S.G., Womack, J., Scholz, I., Renner, A., Edgel, K.A., Xu, G., Ford, J.C., Grey, M., St Laurent, B., and Turner, J.M. (2019). Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge. PLoS ONE, 14. 4. Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection;Marzi;Sci. Rep.,2016 5. Tsuda, Y., Caposio, P., Parkins, C.J., Botto, S., Messaoudi, I., Cicin-Sain, L., Feldmann, H., and Jarvis, M.A. (2011). A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus. PLoS Negl. Trop. Dis., 5.
|
|